Document Detail


Treatment of hyperhidrosis with botulinum toxin.
MedLine Citation:
PMID:  22328694     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Botulinum toxin type A is a safe and effective method for treating focal hyperhidrosis, providing longer-lasting results than topical treatments without the necessity of invasive surgical procedures. Although more useful for axillary hyperhidrosis, botulinum toxin injections can also be effective in treating palmar and plantar disease. The effects of botulinum toxin last for six to nine months on average, and treatment is associated with a high satisfaction rate among patients. In this article, the authors discuss their preferred methods for treating axillary, palmar, and plantar hyperhidrosis. This article serves as guide for pretreatment evaluation, injection techniques, and posttreatment care.
Authors:
Melissa A Doft; Krista L Hardy; Jeffrey A Ascherman
Related Documents :
11223694 - Androstanolone treatment for congenital penile curvature.
21484144 - A comparison of 48-week treatment efficacy between clevudine and entecavir in treatment...
6460494 - Radioisotopic method for measurement of nasal mucociliary activity.
21552054 - Topical sucralfate treatment of anal fistulotomy wounds: a randomized placebo-controlle...
10515084 - Voiding and sexual dysfunctions after pelvic fracture urethral injuries treated with ei...
21712704 - A prospective randomized trial comparing subatmospheric wound therapy with a sealed gau...
Publication Detail:
Type:  Journal Article; Review; Video-Audio Media    
Journal Detail:
Title:  Aesthetic surgery journal / the American Society for Aesthetic Plastic surgery     Volume:  32     ISSN:  1527-330X     ISO Abbreviation:  Aesthet Surg J     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-02-13     Completed Date:  2012-06-04     Revised Date:  2013-09-16    
Medline Journal Info:
Nlm Unique ID:  9707469     Medline TA:  Aesthet Surg J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  238-44     Citation Subset:  IM    
Affiliation:
Division of Plastic Surgery, Department of Surgery, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA. melissadoft@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Botulinum Toxins, Type A / administration & dosage*,  adverse effects,  contraindications
Humans
Hyperhidrosis / drug therapy*,  physiopathology,  psychology
Injections
Neuromuscular Agents / administration & dosage*,  adverse effects,  contraindications
Patient Satisfaction
Quality of Life
Sweating / drug effects*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Neuromuscular Agents; EC 3.4.24.69/Botulinum Toxins, Type A
Comments/Corrections
Comment In:
Aesthet Surg J. 2013 Feb;33(2):295-7   [PMID:  23388650 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The current state of health care reform: the physicians' burden.
Next Document:  Complete genome sequence of bacteriophage phiAS7, a T7-like virus that infects Aeromonas salmonicida...